Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$306.88 - $380.0 $674,522 - $835,240
-2,198 Reduced 98.83%
26 $9,000
Q3 2023

Nov 13, 2023

SELL
$315.92 - $397.36 $42,965 - $54,040
-136 Reduced 5.76%
2,224 $707,000
Q1 2023

May 12, 2023

BUY
$323.56 - $373.36 $177,958 - $205,348
550 Added 30.39%
2,360 $881,000
Q4 2022

Feb 13, 2023

SELL
$248.67 - $334.17 $1.06 Million - $1.43 Million
-4,275 Reduced 70.25%
1,810 $599,000
Q2 2022

Aug 12, 2022

BUY
$301.4 - $428.42 $786,653 - $1.12 Million
2,610 Added 75.11%
6,085 $1.91 Million
Q3 2021

Nov 12, 2021

BUY
$396.76 - $455.92 $1.38 Million - $1.58 Million
3,475 New
3,475 $1.44 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Dsm Capital Partners LLC Portfolio

Follow Dsm Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dsm Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dsm Capital Partners LLC with notifications on news.